Blog

  • NIS2 revamps Ireland’s cybersecurity landscape: Old regulators, new powers

    The NIS2 Directive has significantly reshaped the cybersecurity landscape across the EU. Since the implementation deadline in October 2024, EU Member States have been working to incorporate new standards into their national laws, fostering a dynamic and rapidly evolving regulatory environment. Recently, Ireland’s National Cyber Security Centre (NCSC) published the draft NIS2 Risk Management Measures (RMM) Guidance, which outlines the minimum requirements for essential and important entities.  Ireland has also joined the Cyber Fundamentals Framework (CyFun), originally developed in Belgium, as a scheme co-owner. The CyFun framework offers a structured, risk-based methodology for essential and important entities, assisting them in organising and demonstrating their NIS2 security measures.

    While Ireland has not yet implemented the NIS2 Directive, the legislative process is now at an advanced stage, with the NCSC expecting the National Cyber Security Bill to be transposed into law by the end of the year. As implementation is steadily advancing, it is important to consider how it will impact businesses operating in and through Ireland.

    NIS2’s overall goal is to achieve a high common level of cybersecurity across the EU. Part of this approach requires Member States to establish one or more Competent Authorities responsible for cybersecurity and enforcement. To ensure smooth cross border compliance, a Single Point of Contact on cybersecurity responsible for liaising with other Member States is also required.

     

    Ireland’s NIS2 Strategy: NCSC as Central Liaison with Sectoral Oversight

    Interestingly, Ireland’s proposed implementing legislation takes a different approach to what is outlined in the NIS2 Directive. The NCSC will serve as the Single Point of Contact and act as the Lead Competent Authority, providing advice, guidance, and support to a range of Competent Authorities, each of which will oversee enforcement within their respective sectors. This approach contrasts with Belgium and France for example, where the Centre for Cyber Security Belgium (CCB) and the French Cyber Security Agency (ANSSI) serve as the central authority for all cybersecurity matters. Ireland’s NCSC will act as an overseer. An explanatory note in the Heads of Bill acknowledges that this role does not exist within the NIS2 Directive and “was taken as a policy decision after engagement with the other competent authorities in agreement with the NCSC”.

     

    Regulator Overview

    Article 8 of the NIS2 Directive mandates the designation of Competent Authorities, providing for robust oversight and enforcement. Article 27 requires businesses within the scope of the NIS2 Directive to register with these authorities, ensuring compliance and accountability. The full list of National Competent Authorities along with their designated sectors, as set out in head 17 of the draft Bill is as follows:

     

    NIS2 Regulatory and Oversight Bodies in Ireland
    Sectors
    Commission for the Regulation of Utilities (CRU)
    • Energy
    • Drinking Water
    • Wastewater
    Commission for Communications Regulation (ComReg)
    • Digital Infrastructure
    • ICT Service Management
    • Digital Providers
    • Space
    Central Bank of Ireland (CBI)
    Irish Aviation Authority (IAA)
    Commission for Rail Regulation (CRR)
    The Minister for Transport
    National Transport Authority (NTA)
    Agencies under the remit of the Minister for Health
    National Cyber Security Centre (NCSC)
    • All other sectors set out in Schedule I and II
     
    Main Establishment & Considerations for Digital Service Providers

    The main establishment provision within the NIS2 Directive aims to reduce jurisdictional conflicts and regulatory overlap in the digital services space by creating a ‘one-stop-shop’ for incident reporting obligations. The main benefit derived from these provisions is that entities can report incidents to a single Member State rather than multiple jurisdictions, streamlining compliance and reducing the reporting burden for entities in the midst of large-scale cyber incidents.

    Digital Service Providers looking to avail of the main establishment concept within the NIS2 Directive should note that the Commission for Communications Regulation (ComReg) will be responsible for this sector in Ireland. ComReg has been noticeably proactive in issuing guidance and developing resources in relation to the NIS2 Directive, indicating that it is preparing to play a significant role in enforcement – this will be welcomed by many businesses, given Ireland’s considerable importance as the European or EMEA headquarters for many of the world’s major tech companies.

    Established in 2002, ComReg is a mature, well-resourced statutory body which is responsible for regulating electronic communications and the postal sector in Ireland. ComReg has been instrumental in ensuring compliance throughout the most critical sectors in the Irish economy. Until recently, ComReg was under the leadership of Helen Dixon, who formerly led the Data Protection Commission and was instrumental in its transformation from a small, regionally based office to one of the world’s most influential data protection regulators.

     

    Conclusion

    As Ireland moves closer to full implementation of the NIS2 Directive, we are embracing a distinctive regulatory model that balances central coordination with sector-specific oversight. The NCSC’s role as both the Single Point of Contact and Lead Competent Authority reflects a pragmatic approach tailored to Ireland’s regulatory landscape. With the publication of the draft RMM Guidance and Ireland’s co-ownership of the CyFun framework, the groundwork is being laid for a more structured and resilient cybersecurity regime.

    Proactive engagement with sectoral regulators, especially ComReg for digital services, will be essential to ensure compliance and to leverage the benefits of streamlined reporting and guidance. Digital services providers can expect a well-resourced, tough but fair regulator capable of engaging with both multinational and national businesses. Some digital services providers may be classified as highly critical and subject to stricter enforcement, including proactive measures such as audits. The specifics of enforcement will become clear once the NIS2 Directive is transposed.

    As the National Cyber Security Bill nears enactment, organisations should prepare for a more robust and coordinated cybersecurity environment that aligns with the EU’s broader vision of digital resilience and cross-border cooperation. For further information, please do not hesitate to get in touch with one of the authors or your usual DLA Piper contact.

    Continue Reading

  • No evidence of stolen data in Glasgow cyber attack

    No evidence of stolen data in Glasgow cyber attack

    Glasgow City Council has found no evidence of any data being stolen in a cyber attack that took a number of services offline in June.

    The local authority also says there has been no sign of any data being leaked or misused after the incident, but advised people to remain cautious.

    Technology services supplier CGI discovered malicious activity on servers managed by a third-party supplier on 19 June.

    A number of online services, including paying penalty charges and reporting school absences, became unavailable due to the council taking servers offline.

    No financial systems were affected by the attack and no details of bank accounts or credit/debit cards processed by those systems were compromised.

    A spokesperson for the council said: “As part of our investigation, experts are monitoring online activity and, to date, there has been no evidence of any data being leaked or misused.

    “However, until forensic examinations of the affected servers are complete – and we can be confident whether any data has been stolen – we are advising anyone who has used any of the affected forms to be particularly cautious about contact claiming to be from Glasgow City Council.”

    Some services, such as public freedom of information requests, can be accessed again while workarounds are being developed for other affected systems.

    Police Scotland are involved in investigating the incident, along with the council, the Scottish Cyber Co-ordination Centre and the National Cyber Security Centre.

    A number of Scottish public bodies have been hit by cyber attacks in recent months, including a ransomware group targeting NHS Dumfries and Galloway last year which saw stolen files published online.

    Continue Reading

  • Australian scientists develop green method to produce ammonia gas from air-Xinhua

    SYDNEY, July 4 (Xinhua) — Australian scientists have pioneered a green method to produce ammonia gas from air using artificial lightning, which is low-cost, decentralized and scalable.

    The team has created a more efficient process to produce ammonia gas directly, bypassing earlier methods that first yielded ammonium in solution and required additional steps and energy to obtain the final gas, according to University of Sydney researchers whose study was published Friday.

    Ammonia is typically produced by the energy-intensive and fossil fuel-dependent Haber-Bosch process, an invention in the 19th century, said a statement from the university.

    “In this research, we’ve successfully developed a method that allows air to be converted to ammonia in its gaseous form using electricity,” said the study’s lead researcher, University of Sydney Professor PJ Cullen.

    The plasma-based method Cullen’s team developed uses electricity to excite nitrogen and oxygen molecules in the air. The team then passes these excited molecules to the membrane-based electrolyser to convert the excited molecules to ammonia, according to the study published in Angewandte Chemie International Edition under the German Chemical Society.

    Researchers stressed the need for decentralized and low-cost green ammonia production independent of fossil fuels, noting the team’s plasma-electrolysis process is already energy efficient and scalable, with further improvements underway.

    Continue Reading

  • Q2 2025 Recap: Endocrinology News and Updates

    Q2 2025 Recap: Endocrinology News and Updates

    HCPLive Endocrinology Q2 2025 Recap

    The second quarter of 2025 brought meaningful developments in endocrinology, from FDA actions to clinical breakthroughs spotlighted at major meetings. Several regulatory milestones signaled progress for patients across the spectrum of endocrine disorders, including expanded access to CGM technology, new formulations for adrenal insufficiency, and a broader treatment label for Cushing’s syndrome.

    Novo Nordisk’s NDA for 25 mg oral semaglutide also marked a potential turning point in obesity care, with the first oral GLP-1 formulation for weight management now under review. Meanwhile, June’s ADA Scientific Sessions capped the quarter with a surge of new data on incretin therapies, obesity drugs, and diabetes technology—many with practice-changing potential.

    Here’s a look back at the most impactful regulatory updates and conference highlights shaping the future of endocrine care.

    Regulatory Updates in Endocrinology

    FDA Clears Dexcom G7 15-Day CGM System

    On April 10, 2025, the FDA cleared Dexcom’s G7 15-day continuous glucose monitoring (CGM) system for adults with diabetes, making it the longest-lasting and most accurate CGM approved in the U.S. Based on clinical data showing a MARD of 8.0%, the G7 15 Day demonstrated excellent accuracy and user satisfaction. According to Dexcom, the system offers features like Apple Watch integration, waterproof sensors, and extended wear with a 12-hour grace period for sensor changes. The company plans to ensure compatibility with insulin pump systems ahead of its US launch in late 2025.

    FDA Approves Label Expansion for Osilodrostat for Cushing’s Syndrome

    On April 16, 2025, the FDA approved Recordati’s sNDA for osilodrostat (Isturisa), expanding its indication to include adults with endogenous Cushing’s syndrome who are not surgical candidates or for whom surgery was not curative. Previously approved only for Cushing’s disease, the broader label is supported by data from the LINC 3 and LINC 4 trials showing sustained cortisol reduction and clinical improvement. According to Recordati, osilodrostat offers a vital option for managing hypercortisolemia and preventing severe complications.

    FDA Accepts NDA Submission for Oral Semaglutide 25 mg

    On May 2, 2025, Novo Nordisk announced the FDA accepted its NDA for a once-daily 25 mg oral formulation of semaglutide for chronic weight management in adults with obesity or overweight and at least one comorbidity. Based on results from the 64-week OASIS 4 trial, the oral semaglutide demonstrated significant weight loss and cardiovascular risk reduction. According to Novo Nordisk, this could become the first oral GLP-1 therapy approved for obesity. If approved, it would expand individualized treatment options beyond injectable formulations. An FDA decision is expected in Q4 2025.

    FDA Approves Hydrocortisone Oral Solution for Adrenal Insufficiency

    On May 28, 2025, the FDA approved Eton Pharmaceuticals’ hydrocortisone oral solution (KHINDIVI) for pediatric patients aged 5 and older with adrenocortical insufficiency, marking the first liquid formulation approved for this use. Designed for accurate, individualized dosing, the 1 mg/mL solution helps patients who have difficulty swallowing pills. According to Eton, this ready-to-use formulation eliminates the need for pill-splitting and supports improved treatment outcomes during childhood development.

    American Diabetes Association

    June 2025 also brought several groundbreaking trials and new updates in diabetes care at the 8th American Diabetes Association Scientific Sessions, which were held in Chicago, Illinois from June 20-23, 2025. With multiple sessions dedicated to late-breaking research, the meeting featured multiple simultaneous publications, including a slew of studies related to incretin therapies. To learn more about the meeting’s top news, check out this trio of articles recapping ADA 2025.

    Diabetes Dialogue

    Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD

    In this episode, the hosts discuss new Phase 3 data from the ESSENCE trial showing that once-weekly semaglutide 2.4 mg significantly improved liver outcomes and reduced weight in patients with MASH and stage 2 or 3 fibrosis. They speak with the trial’s lead author about semaglutide’s clinical impact, its potential as a future MASH treatment, and how it compares to the currently approved option, resmetirom.

    Diabetes Dialogue: AACE 2025 Recap

    In this episode, the hosts recap key moments from the 2025 AACE Annual Meeting, covering major plenaries, hands-on tech workshops, and the launch of a new diabetes technology certification program. They spotlight updates on GLP-1 safety, health equity, CGM innovations, and emerging trial data, while reflecting on the future of personalized diabetes care.

    Diabetes Dialogue: Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD

    In this episode, the hosts speak with the Chief Medical Officer of Beta Bionics about real-world outcomes from the iLet Bionic Pancreas, an FDA-cleared fully autonomous insulin delivery system requiring no user settings. They highlight its strong A1c-lowering effect, minimal hypoglycemia, and promise for underserved populations and primary care use, including off-label applications in type 2 diabetes.

    Diabetes Dialogue: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

    In this episode recorded at ADA 2025, the hosts break down results from the REDEFINE 1 and 2 trials showing that CagriSema delivered substantial weight loss and glycemic improvements in people with and without type 2 diabetes. They also discuss the drug’s safety, clinical relevance, and future in obesity care with trial investigators, highlighting upcoming studies like REDEFINE 3.

    Continue Reading

  • Largest Mars rock could sell for a staggering $4 million |

    Largest Mars rock could sell for a staggering $4 million |

    A rare and massive meteorite from Mars, known as NWA 16788, is poised to make headlines as it heads to auction with an estimated price of up to $4 million. Weighing 54 pounds (24.5 kilograms), it is the largest known piece of the Red Planet ever discovered on Earth, making it 70% larger than any previously found Martian meteorite. First unearthed in Niger’s remote Agadez region in November 2023, this extraordinary specimen is not only scientifically significant but also visually striking, with a glassy crust and deep red hues that reflect its Martian origin.

    Martian Rock: A once-in-a-generation discovery

    According to Sotheby’s, the auction house hosting the sale on July 16 in New York, NWA 16788 is among just 400 confirmed Martian meteorites ever found. Its immense size and exceptional condition set it apart from the usual small fragments that survive Earth’s atmosphere. Cassandra Hatton, Vice Chairman of Science and Natural History at Sotheby’s, described it as “a discovery of extraordinary significance… a tangible connection to the Red Planet.” The meteorite likely arrived on Earth after a powerful asteroid impact blasted it from Mars millions of years ago.

    Scientific insights encased in glass

    Analysis reveals that parts of NWA 16788 were turned to glass during its ejection from Mars and again during its fiery descent through Earth’s atmosphere. Planetary scientist Julia Cartwright of the University of Leicester called it a “fabulous rock,” noting that a reference sample is secured at China’s Purple Mountain Observatory, ensuring future scientific study. She emphasized the balance between private collecting and academic access: “Without the market, we wouldn’t have nearly as many samples to study.”

    Public or private? Experts weigh in

    While some scientists, like Professor Steve Brusatte of the University of Edinburgh, express concern that the rock might vanish into a private vault, others recognize the role collectors play. “It would be a shame if it disappeared from public view,” said Brusatte. Cartwright, however, remains optimistic, suggesting the new owner could still collaborate with researchers. The meteorite’s fate may remain unknown after the auction, but its legacy in planetary science is already secured.


    Continue Reading

  • Scientists just found a major flaw in a key COVID drug study

    Scientists just found a major flaw in a key COVID drug study

    The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-Cov-2’s molecular structure known as the NiRAN domain — an enzyme region essential to viral replication that’s common to many coronaviruses. A drug targeting the NiRAN domain would likely work broadly to shut down a range of these pathogens, potentially treating known diseases like COVID as well as helping to head off future pandemics caused by related viruses,

    In 2022, scientists in China (Yan et al.) published a structural model describing exactly how this domain works. It should have been a tremendous boon for drug developers.

    But the model was wrong.

    “Their work contains critical errors,” says Gabriel Small, a graduate fellow in the laboratories of Seth A. Darst and Elizabeth Campbell at Rockefeller. “The data does not support their conclusions.”

    Now, in a new study published in Cell, Small and colleagues demonstrate exactly why scientists still don’t know how the NiRAN domain works. The findings could have sweeping implications for drug developers already working to design antivirals based on flawed assumptions, and underscore the importance of rigorous validation.

    “It is absolutely important that structures be accurate for medicinal chemistry, especially when we’re talking about a critical target for antivirals that is the subject of such intense interest in industry,” says Campbell, head of the Laboratory of Molecular Pathogenesis. “We hope that our work will prevent developers from futilely trying to optimize a drug around an incorrect structure.”

    A promising lead

    By the time the original paper was published in Cell, the Campbell and Darst labs were already quite familiar with the NiRAN domain and its importance as a therapeutic target. Both laboratories study gene expression in pathogens, and their work on SARS-CoV-2 focuses in part on characterizing the molecular interactions that coordinate viral replication.

    The NiRAN domain is essential for helping SARS-CoV-2 and other coronaviruses cap their RNA, a step that allows these viruses to replicate and survive. In one version of this process, the NiRAN domain uses a molecule called GDP to attach a protective cap to the beginning of the virus’s RNA. Small previously described that process in detail, and its structure is considered solved. But the NiRAN domain can also use a related molecule, GTP, to form a protective cap. Determined to develop antivirals that comprehensively shut down the NiRAN domain, scientists were keen to discover the particulars of the latter GTP-related mechanism.

    In the 2022 paper, researchers described a chain of chemical steps, beginning with a water molecule breaking a bond to release the RNA’s 5′ phosphate end. That end then attaches to the beta-phosphate end of the GTP molecule, which removes another phosphate and, with the help of a magnesium ion, transfers the remaining portion of the GTP molecule to the RNA, forming a protective cap that allows the virus to replicate and thrive.

    The team’s evidence? A cryo-electron microscopy image that showed the process caught in action. To freeze this catalytic intermediate, the team used a GTP mimic called GMPPNP.

    Small read the paper with interest. “As soon as they published, I went to download their data,” he says. It wasn’t there. This raised a red flag — data is generally available upon release of a structural biology paper. Months later, however, when Small was finally able to access the data, he began to uncover significant flaws. “I tried to make a figure using their data, and realized that there were serious issues,” he says. Small brought his concerns to Campbell and Darst.

    They agreed. “Something was clearly wrong,” Campbell says. “But we decided to give the other team the benefit of the doubt, and reprocess all of their data ourselves.”

    An uphill battle

    It was painstaking work, with Small leading the charge. Working frame by frame, he compared the published atomic model to the actual cryo-EM map and found something striking: the key molecules that Yan and colleagues claimed to have seen — specifically, the GTP mimic GMPPNP and a magnesium ion in the NiRAN domain’s active site — simply were not there.

    Not only was there no supporting image data, but the placement of these molecules in the original model also violated basic rules of chemistry, causing severe atomic clashes and unrealistic charge interactions. Small ran additional tests, but even advanced methods designed to pick out rare particles turned up empty. He could find no evidence to support the model previously produced by Yan and colleagues.

    Once the Rockefeller researchers validated their results, they submitted their findings to Cell. “It was very important that we publish our corrective manuscript in the same journal that published the original model,” Campbell says, noting that corrections to high-profile papers are often overlooked when published in lower tier journals.

    Otherwise, this confusion in the field could cause problems that reach far beyond the lab bench, Campbell adds — a costly reminder that rigorous basic biomedical research is not just academic, but essential to real-world progress. “Companies keep their cards close to their chests, but we know that several industry groups are studying this,” she says. “Efforts based on a flawed structural model could result in years of wasted time and resources.”

    Continue Reading

  • Beard CB, Eisen L, Eisen RJ. The rise of ticks and tickborne diseases in the United States—Introduction. J Med Entomol. 2021;58:1487–9.

    Article 

    Google Scholar 

  • Sonenshine DE. Range expansion of tick disease vectors in North America: implications for spread of tick-borne disease. Int J Environ Res Public Health. 2018;15:478.

    Article 
    PubMed Central 

    Google Scholar 

  • Day MJ. One health: the importance of companion animal vector-borne diseases. Parasit Vectors. 2011;4:49.

    Article 
    PubMed Central 

    Google Scholar 

  • Skotarczak B. The role of companion animals in the environmental circulation of tick-borne bacterial pathogens. Ann Agric Environ Med AAEM. 2018;25:473–80.

    Article 
    CAS 

    Google Scholar 

  • Burroughs JE, Thomasson JA, Marsella R, Greiner EC, Allan SA. Ticks associated with domestic dogs and cats in Florida, USA. Exp Appl Acarol. 2016;69:87–95.

    Article 

    Google Scholar 

  • Saleh MN, Sundstrom KD, Duncan KT, Ientile MM, Jordy J, Ghosh P, et al. Show us your ticks: a survey of ticks infesting dogs and cats across the USA. Parasit Vectors. 2019;12:595.

    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • Levin ML, Killmaster LF, Zemtsova GE. Domestic dogs (Canis familiaris) as reservoir hosts for Rickettsia conorii. Vector-Borne Zoonotic Dis. 2012;12:28–33.

    Article 

    Google Scholar 

  • Starkey LA, Barrett AW, Chandrashekar R, Stillman BA, Tyrrell P, Thatcher B, et al. Development of antibodies to and PCR detection of Ehrlichia spp. in dogs following natural tick exposure. Vet Microbiol. 2014;173:379–84.

    Article 
    CAS 

    Google Scholar 

  • Yabsley MJ, Adams DS, O’Connor TP, Chandrashekar R, Little SE. Experimental primary and secondary infections of domestic dogs with Ehrlichia ewingii. Vet Microbiol. 2011;150:315–21.

    Article 

    Google Scholar 

  • Beall MJ, Alleman AR, Breitschwerdt EB, Cohn LA, Couto CG, Dryden MW, et al. Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in North America. Parasit Vectors. 2012;5:29.

    Article 
    PubMed Central 

    Google Scholar 

  • Duncan AW, Correa MT, Levine JF, Breitschwerdt EB. The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from Southeastern and Mid-Atlantic states. Vector-Borne Zoonotic Dis. 2005;5:101–9.

    Article 

    Google Scholar 

  • Mead P, Goel R, Kugeler K. Canine serology as adjunct to human Lyme disease surveillance. Emerg Infect Dis. 2011;17:1710–2.

    Article 
    PubMed Central 

    Google Scholar 

  • Paddock CD, Brenner O, Vaid C, Boyd DB, Berg JM, Joseph RJ, et al. Short report: concurrent Rocky Mountain spotted fever in a dog and its owner. Am J Trop Med Hyg. 2002;66:197–9.

    Article 

    Google Scholar 

  • Lappin MR. Update on flea and tick associated diseases of cats. Vet Parasitol. 2018;254:26–9.

    Article 

    Google Scholar 

  • Bouloy RP, Lappin MR, Holland CH, Thrall MA, Baker D, O’Neil S. Clinical ehrlichiosis in a cat. J Am Vet Med Assoc. 1994;204:1475–8.

    Article 
    CAS 

    Google Scholar 

  • Breitschwerdt EB, Abrams-Ogg ACG, Lappin MR, Bienzle D, Hancock SI, Cowan SM, et al. Molecular evidence supporting Ehrlichia canis-like infection in cats. J Vet Intern Med. 2002;16:642–9.

    Google Scholar 

  • Hegarty BC, Qurollo BA, Thomas B, Park K, Chandrashekar R, Beall MJ, et al. Serological and molecular analysis of feline vector-borne anaplasmosis and ehrlichiosis using species-specific peptides and PCR. Parasit Vectors. 2015;8:320.

    Article 
    PubMed Central 

    Google Scholar 

  • Hoyt K, Chandrashekar R, Beall M, Leutenegger C, Lappin MR. Evidence for clinical anaplasmosis and borreliosis in cats in Maine. Top Companion Anim Med. 2018;33:40–4.

    Article 

    Google Scholar 

  • Lappin MR, Breitschwerdt EB, Jensen WA, Dunnigan B, Rha J-Y, Williams CR, et al. Molecular and serologic evidence of Anaplasma phagocytophilum infection in cats in North America. J Am Vet Med Assoc. 2004;225:893–6.

    Article 

    Google Scholar 

  • Savidge C, Ewing P, Andrews J, Aucoin D, Lappin MR, Moroff S. Anaplasma phagocytophilum infection of domestic cats: 16 cases from the northeastern USA. J Feline Med Surg. 2016;18:85–91.

    Article 

    Google Scholar 

  • Lappin MR, Chandrashekar R, Stillman B, Liu J, Mather TN. Evidence of Anaplasma phagocytophilum and Borrelia burgdorferi infection in cats after exposure to wild-caught adult Ixodes scapularis. J Vet Diagn Invest. 2015;27:522–5.

    Article 
    CAS 

    Google Scholar 

  • Little SE, Barrett AW, Nagamori Y, Herrin BH, Normile D, Heaney K, et al. Ticks from cats in the United States: patterns of infestation and infection with pathogens. Vet Parasitol. 2018;257:15–20.

    Article 

    Google Scholar 

  • Smith RC, Starkey LA, Bowles JV, Butler JM, Mount J, Land TM, et al. Nationwide seroprevalence of Dirofilaria immitis antigen and antibodies to Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. in shelter cats in the United States, 2007–2011. Parasitologia. 2024;4:332–44.

    Article 

    Google Scholar 

  • Reichard MV, Sanders TL, Weerarathne P, Meinkoth JH, Miller CA, Scimeca RC, et al. Cytauxzoonosis in North America. Pathogens. 2021;10:1170.

    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • Duplan F, Davies S, Filler S, Abdullah S, Keyte S, Newbury H, et al. Anaplasma phagocytophilum, Bartonella spp., Haemoplasma species and Hepatozoon spp. in ticks infesting cats: a large-scale survey. Parasit Vectors. 2018;11:201.

    Article 
    PubMed Central 

    Google Scholar 

  • Probst J, Springer A, Fingerle V, Strube C. Frequency of Anaplasma phagocytophilum, Borrelia spp., and coinfections in Ixodes ricinus ticks collected from dogs and cats in Germany. Parasit Vectors. 2024;17:87.

    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • Strickland RK. Ticks of Veterinary Importance. Agriculture Department; 1976.

  • Keirans JE, Clifford CM. The genus Ixodes in the United States: a scanning electron microscope study and key to adults. J Med Entomol. 1978;15:1–38.

    Article 

    Google Scholar 

  • Barbour AG, Maupin GO, Teltow GJ, Carter CJ, Piesman J. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis. 1996;173:403–9.

    Article 
    CAS 

    Google Scholar 

  • Little SE, Dawson JE, Lockhart JM, Stallknecht DE, Warner CK, Davidson WR. Development and use of specific polymerase reaction for the detection of an organism resembling Ehrlichia sp. in white-tailed deer. J Wildl Dis. 1997;33:246–53.

    Article 
    CAS 

    Google Scholar 

  • Anderson BE, Sumner JW, Dawson JE, Tzianabos T, Greene CR, Olson JG, et al. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol. 1992;30:775–80.

    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • Dawson JE, Ewing SA. Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am J Vet Res. 1992;53:1322–7.

    Article 
    CAS 

    Google Scholar 

  • Bondy PJ Jr, Cohn LA, Tyler JW, Marsh AE. Polymerase chain reaction detection of Cytauxzoon felis from field-collected ticks and sequence analysis of the small subunit and internal transcribed spacer 1 region of the ribosomal RNA gene. J Parasitol. 2005;91:458–61.

    Article 
    CAS 

    Google Scholar 

  • Reichard MV, Edwards AC, Meinkoth JH, Snider TA, Meinkoth KR, Heinz RE, et al. Confirmation of Amblyomma americanum (Acari: Ixodidae) as a vector for Cytauxzoon felis (Piroplasmorida: Theileriidae) to domestic cats. J Med Entomol. 2010;47:890–6.

    Article 

    Google Scholar 

  • Heise SR, Elshahed MS, Little SE. Bacterial diversity in Amblyomma americanum (Acari: Ixodidae) with a focus on members of the genus Rickettsia. J Med Entomol. 2010;47:258–68.

    Article 
    CAS 

    Google Scholar 

  • Stothard DR. The evolutionary history of the genus Rickettsia as inferred from 16S and 23S ribosomal RNA genes and the 17 kilodalton cell surface antigen gene. Ohio: The Ohio State University; 1995.

    Google Scholar 

  • Randolph SE, Gern L, Nuttall PA. Co-feeding ticks: epidemiological significance for tick-borne pathogen transmission. Parasitol Today. 1996;12:472–9.

    Article 
    CAS 

    Google Scholar 

  • Adams SN, Bestul NC, Calloway KN, Kersh GJ, Salzer JS. National surveillance of human ehrlichiosis caused by Ehrlichia ewingii, United States, 2013–2021. Emerg Infect Dis. 2025;31:222–7.

    Article 
    PubMed Central 

    Google Scholar 

  • Dahlgren FS, Heitman KN, Drexler NA, Massung RF, Behravesh CB. Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data. Am J Trop Med Hyg. 2015;93:66–72.

    Article 
    PubMed Central 

    Google Scholar 

  • Schwartz AM. Surveillance for Lyme disease—United States, 2008–2015. MMWR Surveill Summ. 2017.

  • Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikihisa Y, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 1999;341:148–55.

    Article 
    CAS 

    Google Scholar 

  • Krause PJ, Fish D, Narasimhan S, Barbour AG. Borrelia miyamotoi infection in nature and in humans. Clin Microbiol Infect. 2015;21:631–9.

    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • Shannon AB, Rucinsky R, Gaff HD, Brinkerhoff RJ. Borrelia miyamotoi, other vector-borne agents in cat blood and ticks in eastern Maryland. EcoHealth. 2017;14:816–20.

    Article 

    Google Scholar 

  • Reichard MV, Meinkoth JH, Edwards AC, Snider TA, Kocan KM, Blouin EF, et al. Transmission of Cytauxzoon felis to a domestic cat by Amblyomma americanum. Vet Parasitol. 2009;161:110–5.

    Article 

    Google Scholar 

  • Jones EH, Hinckley AF, Hook SA, Meek JI, Backenson B, Kugeler KJ, et al. Pet ownership increases human risk of encountering ticks. Zoonoses Public Health. 2018;65:74–9.

    Article 
    CAS 

    Google Scholar 

  • Reichard MV, Thomas JE, Arther RG, Hostetler JA, Raetzel KL, Meinkoth JH, et al. Efficacy of an imidacloprid 10%/flumethrin 45% collar (seresto®, bayer) for preventing the transmission of Cytauxzoon felis to domestic cats by Amblyomma americanum. Parasitol Res. 2013;112:11–20.

    Article 

    Google Scholar 

  • Reichard MV, Rugg JJ, Thomas JE, Allen KE, Barrett AW, Murray JK, et al. Efficacy of a topical formulation of selamectin plus sarolaner against induced infestations of Amblyomma americanum on cats and prevention of Cytauxzoon felis transmission. Vet Parasitol. 2019;270:S31–7.

    Article 
    CAS 

    Google Scholar 

Continue Reading

  • Knowledge and practices of dog and cat owners in Mainland Portugal regarding fleas, flea-borne pathogens, and their management | Parasites & Vectors

    Knowledge and practices of dog and cat owners in Mainland Portugal regarding fleas, flea-borne pathogens, and their management | Parasites & Vectors

    Fleas are among the most important worldwide ectoparasites of dogs and cats. Besides being responsible for causing direct deleterious effects such as anaemia and dermatological problems, they are also responsible for the transmission of numerous pathogens, some of which are zoonotic [30]. In Portugal, flea-borne infections have been reported in both companion animals and humans [10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28], highlighting the importance of public education regarding the measures to be taken to reduce the risk of exposure of dogs, cats, and humans to these ectoparasites and the pathogens they transmit. In the present study, a total of 550 companion animal owners in Mainland Portugal responded to a questionnaire regarding fleas, flea-borne pathogens, and their management: 38.5% were dog owners only, 28.7% were cat owners only, and 32.7% owned both animal species. Dog owners usually represent the largest percentage of participants in surveys conducted in the country [33, 34, 39], a trend that might be related to the fact that dogs are the most common pets in Portugal [9] and globally have greater access to veterinary care [41], which increases the frequency of interactions between dog owners and surveys.

    Women made up 69.9% of the participants, which aligns with findings from previous studies on pet ownership, zoonoses, and parasite control awareness [35,36,37,38,39, 42]. This trend is likely related to a higher level of concern among women for the health and well-being of their pets. The mean age of pet owners who responded to the questionnaire was 40 years, and the majority had a secondary or higher level of education, which is similar to what was observed in other studies [35, 36, 38, 39]; this trend may reflect a greater interest among middle-aged adults and individuals with higher educational qualifications to participate in this kind of KP research studies. Geographically, the majority of participants were based in the Área Metropolitana de Lisboa (AML), whereas Algarve had the lowest response rate. Although the questionnaire was distributed through several veterinary clinics across Mainland Portugal, the number of participating clinics in the Algarve was relatively low, potentially influencing respondent numbers. This distribution pattern is consistent with previous national studies [34], [42] and may reflect regional variations in interest levels or cultural differences in pet care practices and perceptions.

    Few studies have assessed companion animal owners’ level of knowledge regarding fleas and flea-borne pathogens [32, 35]. In a study from Hungary [32], most dog and cat owners were unaware that fleas can harm both animals and humans or that the environment can be a source of infestation, while in a study from Malaysia [35] about 40% of cat owners recognised fleas as pathogen vectors and were aware that infestations can originate from the environment. In addition, more than half of the Malaysian cat owners were also able to identify the size, food source, and movement of the fleas, which could be because most of the responders had previously experienced flea infestations in cats. In this study, over 70% of participants correctly identified the flea’s body colour and movement, while more than half recognised its size and diet, demonstrating a reasonable understanding of flea biology. Companion animal owners also recognised the environment, mainly outdoor spaces, and contact with infested animals as common sources of flea infestations, as well as the fact that fleas may remain active year-round, reflecting their awareness of the flea life cycle. Interestingly, cat-only owners were significantly more aware than the other two owner groups that fleas have a flat body shape, and that indoor environments and humans can also be a source of infestation. In contrast to previous studies [32, 35], most participants recognised fleas as vectors of pathogens affecting both animals and humans, with bites being the most commonly known transmission route. However, as in previous studies, only a few could name the specific etiological agents. Knowledge about pathogen transmission through scratches was significantly higher among cat-only owners. Although the identification of pathogens did not differ among the three groups, cat-only owners most frequently mentioned the etiological agents of cat-scratch disease and mycoplasmosis, while D. caninum was more frequently noted by dog-only and dog+cat owners, suggesting that some participants were able to correctly associate certain pathogens with the animal species they affect.

    In this study, multivariate analysis confirmed trends observed in previous CPP questionnaires regarding sex, age, and education level. Specifically, a higher awareness of fleas and flea-borne pathogens was associated with participants who had higher education, were under 50 years of age (Kf only), and were female (Kp only). Knowledge was also higher among participants living in the AML, Centro, and Algarve regions. Interestingly, despite the low number of participants from the Algarve region, their greater knowledge may be linked to the participation of individuals particularly concerned about the seriousness of these ectoparasites.

    The considerable ability of participants to recognise fleas, to associate flea presence with changes in animals’ behaviour, and to understand the role of these ectoparasites in pathogen transmission may be attributed to information provided by veterinarians or previous experiences with flea infestations in their companion animals. In fact, about two-thirds of the participants reported prior flea infestations, which may have prompted them to seek advice from veterinarians, the most common reported source of information on fleas and flea-borne pathogens, followed by social media and the internet. The acquisition of information about zoonotic infections from veterinarians emphasises their important role in raising the awareness of owners about the ways of transmission of the pathogens to their pets and themselves [35], although in some cases the proactivity of veterinarians in passing on knowledge has been considered negligible [36, 39]. Routine consultations provide an important opportunity for veterinarians to educate owners about the health risks fleas pose. To enhance the impact of these interactions, clear and simple educational materials, such as brochures, posters, and infographics, can be displayed in clinic waiting areas to reinforce key messages and support owner understanding. Curiously, and despite the fact that advertisements on TV about the application of ectoparasiticides to prevent arthropods and vector-borne infections was a common source of information identified in previous studies [36, 43], in the present study very few participants reported the use of this communication channel to obtain information about fleas and flea-borne pathogens. Similarly, the low demand for information on these topics from physicians (less than 10% of participants) suggests that healthcare professionals are not perceived as key sources of education on the risks of vector-borne zoonotic agents for pet-owning patients [44].

    To effectively avoid and eliminate fleas, prevent flea-borne infections, and manage flea allergy dermatitis, an integrated control strategy should target both immature and adult flea stages. This strategy may involve using products containing insect growth regulators or juvenile hormone analogues, formulations with repellent or fast-killing properties, or those with combined effects on both the animal and its environment. To prevent and eliminate infestations, a range of products are available in various formulations, including collars, spot-on treatments, sprays, powders, shampoos, chewable or hard tablets, and injectables [30, 45].

    ESCCAP recommends year-round flea prevention to cover the complete activity period of the ectoparasite, as exposure is difficult to avoid [31].

    Portugal has a temperate Mediterranean climate [46], which likely creates favourable conditions for flea populations to persist throughout the year. This climate, characterized by mild winters and warm to hot summers, combined with the common outdoor access granted to pets, increases the risk of flea infestation and underscores the need for continuous preventive measures. Most participants stated that their companion animals were treated against fleas as a preventive measure, aligning with previous studies on ectoparasite control practices among dog and cat owners [33, 34, 39, 47]. About half of the participants treated their pets for ectoparasites every 3 to 4 months, followed by every 6 to 8 months, and once per month. The preference for spot-on treatments among cat owners aligns with other studies, likely due to their ease of application [47]. Similarly, oral tablets were less commonly referred to as being used by this group, probably because cats are considered to be difficult to medicate orally [47]. As the questionnaire did not include the active ingredient of the products used, the accuracy of their application according to the manufacturer’s recommendations cannot be assessed. Given that spot-on treatments were the most commonly used route among cat-only owners and owners of both animal species, and with few exceptions are effective for only 3–4 weeks, it is likely that many pets were not treated at the correct frequency. The same conclusion can be drawn for the administration of ectoparasites in tablet form, the second most commonly used product by dog owners and owners of both animal species, since the treatment schedule is between 4 and 12 weeks. Reasons for non-compliance may relate to a lack of awareness about the importance of continuous prevention, the absence of infestation (thus reducing adherence to long-term prevention protocols), or financial constraints, with the latter reported by 15.4% of participants. Flea treatment rates for all animals in the household were significantly lower among dog and cat owners than among those who owned only dogs or only cats, although the overall frequency of flea treatment did not differ significantly between these groups. A survey of dog owners in Thailand found that the cost of flea and tick prevention, especially in households with multiple dogs, was linked to less frequent use of preventive treatments. Most owners tended to use products only when their dogs were infested [37]. In the present study, only a small percentage of participants claimed to treat their animals only when fleas were detected.

    Effective prophylactic treatment should be used in conjunction with environmental control to target all life stages. Mechanical environmental measures such as frequent vacuuming, washing pet bedding, and cleaning all areas that may harbour eggs can significantly reduce the household flea burden [6, 32, 50]. Interestingly, cleaning, vacuuming, and applying insecticides to the house and the animal’s resting places, along with brushing the animal, were the most frequently mentioned measures for controlling infestation, suggesting that many owners are aware of the importance of these practices in managing flea infestations. Cat-only owners were significantly more likely to choose the practice of cleaning areas with a possible higher risk of infestation and presented greater willingness to ask veterinarians for advice on preventing and controlling fleas. This, together with their greater knowledge of flea morphology and the fact that indoor environments and humans can also be sources of infestation, indicates a previous history of contact with fleas. In fact, 53.2% of the respondents of this group reported prior experience with fleas, which likely explains a greater motivation to apply preventative measures. Interestingly, a significantly higher proportion of participants in this group reported keeping their animals indoors from sunset to sunrise as a control measure. This may reflect confusion with other insects active during that time, such as mosquitoes and phlebotomine sand flies.

    As mentioned earlier, multivariate analysis indicated that higher education was associated with greater knowledge of fleas and flea-borne pathogens. However, this knowledge did not lead to a higher adoption of protective practices. This discrepancy could be related to the perception that general protective measures against arthropods and arthropod-borne infections are also effective against fleas, suggesting that specific flea control measures may be unnecessary.

    Conversely, higher practice scores were observed in owners under 60 years old, those living in the AML or Centro regions, and those owning only cats or only dogs. This may reflect a greater concern for preventive measures among middle-aged participants and individuals with higher knowledge of fleas and flea-borne pathogens. Additionally, owning a single species might lead to more focused and effective infestation prevention strategies.

    Although over 30% of Portuguese households owned at least one dog or cat in 2022, respondents in this study came from only 86 of the 278 municipalities in Mainland Portugal. This limited geographical representation may have hindered a detailed analysis of how sociodemographic differences influence knowledge about fleas, the diseases they can cause, and management measures for these ectoparasites. As a result, the study’s ability to accurately identify trends in pet owners’ KP may have been affected. Future research should address this limitation by ensuring broader geographical representation, thereby strengthening the reliability of the findings.

    Another limitation was the absence of including the residence of companion animal owners, as animals living in rural areas are more exposed to fleas, which may influence the awareness of the owners regarding these ectoparasites and their management.

    Continue Reading

  • FiiO K15 is a versatile, feature-packed headphone amp and streaming DAC

    FiiO K15 is a versatile, feature-packed headphone amp and streaming DAC

    The FiiO K15 isn’t just a DAC and headphone amplifier. The new unit also acts as a preamplifier and a streamer, with a host of flexible connections and streaming methods available.

    Set for release on 1st August, this versatile model will cost $549 / £499 / €599 (Australian release and pricing information TBC).

    Continue Reading

  • French air traffic controllers' strike disrupts flights for second day – Reuters

    1. French air traffic controllers’ strike disrupts flights for second day  Reuters
    2. Ryanair cancels flights for 30,000 passengers due to French strike  BBC
    3. Europe’s Airline Sector Grounded by Strikes: Why Investors Must Seek Diversification and Regulatory Solutions  AInvest
    4. Traffic jams and strikes: Travel in France on first summer holiday weekend  The Local France
    5. Ryanair calls for EU chief’s head, following French ATC chaos  Aviation Business News

    Continue Reading